C12N 2730/10152
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2730/10152 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 3 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 6
- Assignees
- 8
- Inventors
- 18
- Latest grant
- 14 Apr 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 2 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Development of HBV-and/or HDV-susceptible cells, cell lines and non-human animals14 Apr 2020US 10,618,947 B2Ruprecht-Karls-UniversitäT Heidelberg
- Vaccine combinations28 Aug 2018US 10,058,605 B2Bharat Biotech International Limited
- Methods for producing cells having a phenotype of a primary human hepatocytes and compositions15 May 2018US 9,969,979 B2The Governors of the University of Alberta
- Vaccine compositions and methods of use thereof16 May 2024US 2024/0156948 A1Excepgen Inc.
- Hepatitis b virus vaccine and uses thereof20 Jan 2022US 2022/0016231 A1JRHS Therapeutics Inc.
- Vaccine combinations21 Jan 2016US 2016/0015804 A1Bharat Biotech International Limited
- Development of hbv-and/or hdv-susceptible cells, cell lines and non-human animals22 Oct 2015US 2015/0299289 A1Ruprecht-Karls-Universitaet Heidelberg
- Methods for Producing Cells Having a Phenotype of a Primary Human Hepatocytes and Compositions2 Jul 2015US 2015/0184124 A1The Governors of the University of Alberta
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.